|  | Time (hours) | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 |  |  |  |  | Continuous rate infusion |  |  |  |  |  |  |  | ||
 |  | 0 | 1.5 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 12 | 14 | 24 |
Lameness score | Me | 0 (0–0) | 1.5 (0.5-2)* | 4 (3.5-4) | 3.5 (3–4) | 2 (2–2.5)a | 1 (1–1.5)*a | 1.5 (0.5-2)*a | 1.5 (1–2)* | 1 (1–1.5)* | 1 (1–1.5)* | 1.5 (1–2)* | 1 (1–1.5)* | 0 (0–0)* |
Mo | 0 (0–0) | 3 (2–3) | 4 (4–4) | 4 (3.5-4) | 3 (3–4)ab | 2 (2–3)*a | 2.5 (2–3)*a | 2 (2–3)* | 2 (2–3)* | 2 (2–2.7)* | 2 (1.2-2.7)* | 2 (1.2-2.7)* | 0 (0–1)* | |
B | 0 (0–0) | 2 (2–3)* | 4 (4–4) | 4 (4–4) | 4 (4–4)ab | 4 (4–4)b | 3 (2.5-3)a | 2 (1.5-3)* | 2 (1–3)* | 2 (1–3)* | 1.5 (0–2.2)* | 1.5 (0–2)* | 0 (0–0)* | |
T | 0 (0–0) | 3 (2.7-3) | 4 (3–4) | 4 (3.7-4) | 4 (3–4)b | 4 (3–4)b | 3.5 (3–4)b | -- | -- | -- | -- | -- | 0 (0–0)* | |
Trial | 0 (0–0) | 3 (3–3) | 4 (4–4) | 4 (4–4) | 4 (4–4) | 4 (4–4) | 4 (4–4) | 4 (4–4) | 3.5 (3–4) | 4 (4–4) | 3 (3–3) | 3 (3–3) | 1.5 (1–2) |